Sign inGet started

McCann Corey

Insider CIK 1881049 · PEAR President and CEO, Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
PEAR Pear Therapeutics, Inc. A Award deriv2023-02-152023-02-172,857,142— $02,857,142SEC↗
PEAR Pear Therapeutics, Inc. S Sale2023-01-202023-01-2434,731$1.13 $39.2K8,210,834SEC↗
PEAR Pear Therapeutics, Inc. M Exercise deriv2023-01-142023-01-1888,000— $0178,667SEC↗
PEAR Pear Therapeutics, Inc. M Exercise2023-01-142023-01-1888,000— $08,245,565SEC↗
PEAR Pear Therapeutics, Inc. A Award deriv2022-02-162022-02-18266,667— $0266,667SEC↗
PEAR Pear Therapeutics, Inc. A Award deriv2022-02-162022-02-18210,080— $0210,080SEC↗
PEAR Pear Therapeutics, Inc. A Award2021-12-032021-12-07986,517— $0986,517SEC↗
PEAR Pear Therapeutics, Inc. A Award2021-12-032021-12-078,157,656— $08,157,656SEC↗
PEAR Pear Therapeutics, Inc. A Award2021-12-032021-12-071,685,913— $01,685,913SEC↗